We dosed mice with BE-AAVs 1 week before pathogenic prion inoculation for the following reasons: first, the age-associated penetrance of prion disease mutation provides an opportunity for prophylaxis in pre-symptomatic PRNP mutation carriers, a large majority of whom are negative for prion seeding activity27. Here, PRNP is linked to prion disease.